Programmable and Switchable RNA Scaffolds for Synthetic Condensate Engineering in Mammalian Cells

preprint OA: closed
Full text JSON View at publisher

Abstract

ABSTRACT The ability to engineer synthetic biomolecular condensates in living cells offers new opportunities to control intracellular organization, yet robust and programmable RNA-based systems have remained limited. Here, we introduce genetically encoded, modular platforms that generate RNA-driven condensates using nanostar-derived scaffolds. Systematic comparison of repeat-based and de novo designs identified nanostar variants that reliably assemble nuclear condensates in mammalian cells. Unexpectedly, condensate formation in cells is governed primarily by double-stranded RNA stems that recruit endogenous RNA-binding proteins, rather than by the kissing-loop interactions that drive assembly in vitro . This mechanistic shift highlights the divergence between cellular and in vitro environments and accounts for the limited orthogonality among scaffolds. Sequence refinement to reduce nonspecific pairing improved homotypic assembly and enhanced orthogonality. We further demonstrated functional compartmentalization by recruiting protein and RNA clients to modulate their stability and activity, and we incorporated an acyclovir-responsive allosteric switch to achieve reversible, small-molecule control of condensation. Together, this work establishes a versatile RNA-based toolkit for constructing programmable cellular compartments, advancing strategies for controlling RNA–protein organization and enabling new biosensing and therapeutic applications.
Full text 1,543 characters · extracted from oa-doi-fallback · click to expand
ABSTRACT The ability to engineer synthetic biomolecular condensates in living cells offers new opportunities to control intracellular organization, yet robust and programmable RNA-based systems have remained limited. Here, we introduce genetically encoded, modular platforms that generate RNA-driven condensates using nanostar-derived scaffolds. Systematic comparison of repeat-based and de novo designs identified nanostar variants that reliably assemble nuclear condensates in mammalian cells. Unexpectedly, condensate formation in cells is governed primarily by double-stranded RNA stems that recruit endogenous RNA-binding proteins, rather than by the kissing-loop interactions that drive assembly in vitro. This mechanistic shift highlights the divergence between cellular and in vitro environments and accounts for the limited orthogonality among scaffolds. Sequence refinement to reduce nonspecific pairing improved homotypic assembly and enhanced orthogonality. We further demonstrated functional compartmentalization by recruiting protein and RNA clients to modulate their stability and activity, and we incorporated an acyclovir-responsive allosteric switch to achieve reversible, small-molecule control of condensation. Together, this work establishes a versatile RNA-based toolkit for constructing programmable cellular compartments, advancing strategies for controlling RNA–protein organization and enabling new biosensing and therapeutic applications. Competing Interest Statement The authors have declared no competing interest.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00